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Thrombolytic therapy for peripheral vascular disease 
Anthony J. Comerota, Philadelphia, 1994, JB Lippin- 
cott, 553 pages, $89. 
Dr. Comerota has assembled a well-organized and 
comprehensive t xt with contributions from a number of 
collaborating authorities who have expertise in throm- 
bolytic therapy. The text contains 30 chapters and 535 
pages organized in a logical, easily followed sequence. In 
the first four chapters, the normal mechanisms of hemo- 
stasis are presented. In chapters 5 to 11, the various 
thrombolytic agents are discussed and compared. With this 
as background, chapters 12 to 26 systematically describe 
clinical indications for thrombolytic therapy. Included are 
reviews of the role of thrombolytics in the treatment of 
venous disease and pulmonary embolus (chapters 12 to 
15), arterial thrombosis and graft occlusion (chapters 16 to 
23), and stroke and myocardial infarction (chapters 24 to 
26). In the final chapters, complications ofthrombolysis are 
discussed, along with several new lytic and anticoagulant 
agents not yet clinically available. 
The prejudice of the authors in favor of thrombolytic 
therapy is evident, although the text makes it quite clear 
that, for most thrombolytic disorders, well-controlled 
randomized trials comparing thrombolytic therapy to more 
conventional forms of treatment are lacking. The uncritical 
reader may rapidly acquire an overly optimistic view of the 
usefulness of lyric therapy for many diseases. However, in 
most chapters, available literature is appropriately re- 
viewed, and the limitations and complications of lyric 
techniques are acknowledged. The chapter that addresses 
thrombolysis for failed lower extremity grafts is particularly 
well written and referenced. After an analysis of the current 
literature, the author appropriately concludes: "Although 
the ultimate role of regional thrombolysis n patients with 
occluded grafts remains to be established, the potential 
value of this technique has been documented in many small 
series and individual patients.'" 
The success of thrombolytic therapy is often related to 
the technical expertise of the interventionalist. In many of 
the chapters, the author's approach to thrombolysis is 
discussed, allowing the reader to gain insight into the 
techniques that make for success of this treatment. Chapter 
16, which provides an overview of thrombolytic therapy 
for arterial and graft occlusion, is particularly useful in this 
regard. 
Thrombolytic Therapy for Peripheral Vascular Disease can 
serve as a comprehensive reference for those seeking 
additional information about he hematologic complexities 
that contribute to coagulation and thrombosis. More 
practically, this text permits the practicing vascular surgeon 
to quickly review current indications for, and success of, 
thrombolytic treatment in a variety of frequently encoun- 
tered disease states. Although the author's enthusiasm is
126 JOURNAL OF VASCULAR SURGERY/Jtdy 1995 
evident, the main limitation is the lack of controlled trials 
precisely identifying the circumstances in which these 
agents may be best used. On balance, this is a well-written 
book fairly presenting available vidence. I recommend this 
book as an excellent reference for all vascular surgeons. 
K. Craig Kent, MD 
Harvard Medical School 
Boston, Mass. 
Thrombin, thrombomodul in and the control of 
hemostasis 
John C. Giddings, Austin, 1994, KG Landes, 186 
pages, $89.95. 
It is becoming increasingly apparent that modulation 
of hemostasis important in clinical vascular surgery and 
that the endothelium plays a pivotal role in this process. 
Thrombin, Thrombomodulin, and the Control of Hemostasis 
a detailed overview of the hemostatic process, with 
particular attention to the interactions between thrombin, 
thrombomodulin, associated coagulation factors, and the 
vascular endothelium. This volume is extremely well 
written and provides a thorough, up-to-date discussion of 
the topic. Although there are several authors, Giddings is 
the editor and primary author, and there is little overlap 
between chapters in this tighdy organized book. Each 
subject is introduced with a review of the pertinent basic 
science, which leads in logical progression to extensive 
discussion of the relevant molecular biology, molecular 
genetics, and cellular biology. Thus, although the book is 
directed primarily at researchers and scholars, its informa- 
tion is accessible to those at all levels of understanding. 
The book begins by introducing the nature of the 
relationships between thrombin, thrombomodulin, and 
the vascular endothelium that serve to maintain the balance 
between hemostasis and fibrinolysis. Concise summaries of 
the processes of coagulation and fibrinolysis and the 
naturally occurring inhibitors of these processes follow and 
provide the basis for subsequent discussion of the interac- 
tions between the titular elements. Much of the clinically 
relevant material in this work is included in the chapter on 
inhibitors. The mechanism of action of fibrinolytic agents 
is explained, as is the molecular basis of the prothrombotic 
states associated with protein C and S deficiencies and 
antithrombin III deficiency. The book would assume 
greater value to the clinician with expansion of these 
sections. The discussion of protein C and S deficiencies was 
particularly limited. 
The main focus of the book, the molecular biology of 
the thrombin-thrombomodulin interaction, and the role of 
the vascular endothelium in this process, is the topic of 
subsequent chapters. The structure, function, and regula- 
